Pharmaceutical and Life Sciences companies have caught the omnichannel bug. Around the world they are quickly forming teams and investing millions. Often, these initiatives are led by highly competent staff who have years of pharma experience but who are suddenly being asked to develop and execute on content strategies and platforms vastly more complex than anything the company has done before; all while maintaining quality, compliance, and staff morale.
It’s a tall order. This session uses case studies from the likes of Eli Lilly, Roche, 3M Lifesciences and more to clearly define why and how of proven strategies and tactics that can help a pharma company move towards omnichannel. We’ll look at how to be successful in implementing methods like component content (aka atomic, aka modular, aka structured, aka reusable, aka “like Lego”…); omnichannel data and analytics integration; and tagging and categorising for personalisation and regional compliance at scale.
Examples will be relevant for various parts of the enterprise across the reactive/proactive commercial/informational spectrum.